Skip to main content

Table 2 Pathways that are enriched among target genes of miRNA-152-3p

From: The expression of miRNA-152-3p and miRNA-185 in tumor tissues versus margin tissues of patients with chemo-treated breast cancer

Gene set

Pathway name

FDR

P-value

Fold enrichment detail

hsa05215

Prostate cancer

5.9238E−6

2.8840E−9

O = 11; E = 0.96; R = 11.37

R-HSA-8943723

Regulation of PTEN mRNA translation

8.1607E−6

1.1011E−8

O = 5; E = 0.08; R = 55.72

hsa04151

PI3K-Akt signaling pathway

8.1607E−6

1.1919E−8

O = 18; E = 3.52; R = 5.10

hsa05206

MicroRNAs in cancer

1.5061E−5

2.9330E−8

O = 12; E = 1.49; R = 8.02

hsa04550

Signaling pathways regulating pluripotency of stem cells

5.2459E−5

1.2770E−7

O = 11; E = 1.38; R = 7.93

hsa05224

Breast cancer

6.8102E−5

2.2617E−7

O = 11; E = 1.46; R = 7.50

hsa05165

Human papillomavirus infection

6.8102E−5

2.3209E−7

O = 16; E = 3.37; R = 4.73

R-HSA-426496

Post-transcriptional silencing by small RNAs

8.2303E−5

3.2056E−7

O = 4; E = 0.06; R = 57.32

hsa05214

Glioma

1.0421E−4

4.8141E−7

O = 8; E = 0.70; R = 11.30

R-HSA-8934593

Regulation of RUNX1 Expression and Activity

1.0421E−4

5.0736E−7

O = 5; E = 0.16; R = 29.50

  1. E number of expected gene in the category, FDR false discovery rate, O number of observed target genes in the category, R fold enrichment